Lymphoma Clinical Trials & Research

Share

Our mission at MSK has always been to care for and cure people with cancer. As part of this goal, we’ve worked for decades to find new treatments. Many of our innovations and approaches have set the standard for care.

The MSK Lymphoma Service has one of the largest and most innovative clinical trial programs in the world. We offer a diverse range of treatment options for patients with Hodgkin and non-Hodgkin lymphoma. Because of our active clinical trial research program, we have helped to develop most of the lymphoma drugs that have improved patient outcomes and are currently FDA approved. Many of our clinical trials turn the latest discoveries from the laboratory into new treatments for patients with lymphoma.

Choosing MSK may give you access to new treatment options that are not yet readily available and could turn out to be tomorrow’s cures. We have extensive experience in matching patients with the clinical trials that will benefit them the most.


Burkitt’s Lymphoma

Newly Diagnosed/Frontline Studies and Advanced Disease

Prior Treatment (Relapsed/Refractory)

A Phase I Study of KT-333 in People with Lymphoma and Large Granular Lymphocytic Leukemia
Zachary Epstein-Peterson
[Protocol 22-348]

A Phase 2 Study of Nanatinostat and Valganciclovir in People With Lymphoma
Zachary Epstein-Peterson
[Protocol 23-115]

Chronic Lymphocytic Lymphoma (CLL)
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
HIV+ Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Marginal Zone Lymphoma

Newly Diagnosed/Frontline Studies and Advanced Disease

Prior Treatment (Relapsed/Refractory)

A Phase I Study of KT-333 in People with Lymphoma and Large Granular Lymphocytic Leukemia
Zachary Epstein-Peterson
[Protocol 22-348]

A Phase 1/2 Study of IPH6501, a Novel Immunotherapy, in People With Non-Hodgkin Lymphoma
Lorenzo Falchi
[Protocol 23-340]

Mediastinal Grey Zone Lymphoma

Newly Diagnosed/Frontline Studies and Advanced Disease

Prior Treatment (Relapsed/Refractory)

A Phase I Study of KT-333 in People with Lymphoma and Large Granular Lymphocytic Leukemia
Zachary Epstein-Peterson
[Protocol 22-348]

Small Lymphocytic Lymphoma (SLL)
Peripheral T-cell Lymphoma
Cutaneous T-cell Lymphoma
NK T-cell Lymphoma
Waldenstrom’s Macroglobulinemia

Newly Diagnosed/Frontline Studies and Advanced Disease

Prior Treatment (Relapsed/Refractory)

A Phase II Study of CLR 131 in People with Central Nervous System Lymphoma
Christian Grommes
[Protocol 21-436]

A Phase I Study of KT-333 in People with Lymphoma and Large Granular Lymphocytic Leukemia
Zachary Epstein-Peterson
[Protocol 22-348]

Request an Appointment

Call 646-497-9137
Available Monday through Friday, to (Eastern time)